You are here: Industry Insights > Cancer

News List

Scientists identify targets for COVID-19 vaccine using cancer immunotherapy tools worldpharmanews
June 10, 2020
Cancer researchers at Children's Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine...
AstraZeneca teams up with Accent Therapeutics for cancer therapies pharmaceutical-technology
June 05, 2020
The partners aim for therapeutics that act on RNA-modifying proteins (RMPs) to treat cancer.
Coronavirus bottleneck leaves 2m waiting for cancer care pharmatimes
June 04, 2020
Around 2.4 million people in the UK are currently waiting for cancer screening, tests or cancer treatment, a new analysis by Cancer Research UK has found.
UK study highlights potential of genetic screening for prostate cancer pharmatimes
June 02, 2020
Findings of pioneering study unveiled at ASCO 2020 show that genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease in seemingly healthy males.
Gilead and Arcus Ink $2B Cancer Partnership contractpharma
June 01, 2020
To co-develop and co-commercialize next-generation cancer immunotherapies.
Researchers develop AI tool able to predict cancer relapse pharmatimes
May 29, 2020
A team of computer scientists and pathologists have trained an artificial intelligence (AI) tool to identify lung cancer patients who have a higher risk of disease recurrence following treatment.
Gilead and Arcus Biosciences partner to develop cancer drugs pharmaceutical-technology
May 29, 2020
Gilead Sciences has partnered with Arcus Biosciences to jointly develop and commercialise current and future cancer therapeutic candidates in the latter’s pipeline.
NICE issues final guidance on NHS use of Bayer's Vitrakvi pharmatimes
May 28, 2020
The National Institute for Health and Care Excellence (NICE) has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety of cancers.
Roche partners with Vividion on novel E3 Ligases pharmatimes
May 21, 2020
Roche has signed up for access to Vividion Therapeutics' proteomics screening platform and proprietary small molecule library to target E3 ligases and a range of oncology and immunology therapeutic targets.
COVID-19 related delays to cancer treatment could cost thousands of lives, research shows pharmatimes
May 21, 2020
Scientists at the Institute of Cancer Research (ICR) are warning that delays to cancer surgery and other treatment caused by the COVID-19 pandemic could be linked to thousands of additional deaths in England.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page